Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
spondylarthritis
MeSH D025241 - spondylarthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001168:
Arthritis
15 Companies
8 Drugs
$
Success rate
D013166:
Spondylitis
0 Companies
0 Drugs
Success rate
D025241:
Spondylarthritis
9 Companies
1 Drug
$
Success rate
D025242:
Spondylarthropathies
0 Companies
0 Drugs
Success rate
D055013:
Spine osteoarthritis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
1/1
Phase 3
80
%
4/5
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Diclophenac
Pfizer
Bevifimod
,
Czp
,
Articular
,
Diclophenac
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use